Newsroom

News

The Faculty of Medicine has awarded Professor Dirk Heinz an honorary doctorate – for his outstanding achievements in the fields of structural biology and infection research as well as for his shaping the German research landscape for the better.

08.11.2022

HZI Campus

News

With the help of the eHealth system SORMAS (short for “Surveillance Outbreak Response Management and Analysis System”), epidemics can be detected and contained at an early stage. For its contribution to global health, the system developed under the leadership of the Helmholtz Centre for Infection Research (HZI) in Braunschweig has now been rewarded with a place among the three finalists for the Zayed Sustainability Award 2023. The winner of the $600,000 prize will be selected in January 2023 from the three selected projects, which competed against more than 900 other projects in the health category.

07.11.2022

HZI Campus

News

Scientists at the Helmholtz Institute for RNA-based Infection Research (HIRI) and the Institute for Molecular Infection Biology (IMIB) in Würzburg want to better understand how the oral cavity germ Fusobacterium nucleatum is exactly linked to various cancer diseases. To unravel the molecular strategies of these bacteria, the team has developed new genetic tools. They discovered an adaptation factor that may help the microorganisms colonize tumor cells. The findings contribute to the search for new therapeutic targets and were published recently in the journal PNAS (The Proceedings of the National Academy of Sciences).

03.11.2022

HIRI

News

The Federal Agency for Disruptive Innovation (SPRIND) is pleased to announce the participants of the second phase of the SPRIND Challenge "A Quantum Shift for New Antiviral Agents". Six teams will each receive up to 1.5 million for the next twelve months to further develop new drug candidates against viral diseases. The team “PROTAC-powered antivirals” led by Prof Mark Brönstrup, head of the department “Chemical Biology” at the Helmholtz Centre for Infection Research (HZI) in Braunschweig, receives funding for the development of a platform for broadly effective antiviral agents. In addition, the team “Mucboost” with participation of Dr Christian Sieben, head of the junior research group “Nano Infection Biology” at the HZI, will continue to receive funding. The “CRISPR Antivirals” team includes two HZI researchers, Prof Chase Beisel, head of the department “RNA Synthetic Biology” at the Helmholtz Institute for RNA-based Infection Research (HIRI), and Prof Claus-Michael Lehr, head of the department “Drug Delivery across Biological Barriers” at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS). HIRI and HIPS are HZI sites in cooperation with Julius Maximilians University (JMU) Würzburg and Saarland University, respectively.

26.10.2022

HZI Campus

HIPS

HIRI

Interview

Martin Korte researches the influence of infections and infection-associated inflammations on neurodegenerative diseases that damage, for example, learning processes or memory. Korte is group leader of the “Neuroinflammation and Neurodegeneration” research group at the Helmholtz Centre for Infection Research (HZI) and director of the Zoological Institute at the Technische Universität Braunschweig where he also holds a professorship for Cellular Neurobiology. A newly emerging field of research are the symptoms summarily known as "long COVID", which continue to manifest for months in about ten per cent of patients after overcoming a COVID-19 disease. In this interview, Martin Korte explains these long-term consequences, which are the subject of his new book (in German).

15.10.2022

HZI Campus

News

Many people suffer from neurodermatitis (atopic dermatitis) or psoriasis. These chronic inflammatory diseases, which have so far been incurable, can lead to a significant loss of quality of life due to the agonising itching and stigmatisation in severe forms. Researchers of the exzellence cluster RESIST have now gained a number of new insights with potential clinical relevance using state-of-the-art technologies such as T-cell receptor and single-cell RNA sequencing based on skin biopsies and blood samples from patients. They have published these in the journal Allergy, currently the leading publication in the field of allergology, in two articles. The main authors include Dr Bowen Zhang from the research group of Prof Yang Li, Centre for Individualised Infection Medicine (CiiM) and TWINCORE - Centre for Experimental and Clinical Infection Research, and Dr Lennart Rösner and Dr Stephan Traidl from the team of Prof Thomas Werfel, Clinic for Dermatology, Allergology and Venereology at Hanover Medical School (MHH). The CiiM and TWINCORE are joint institutions of the Helmholtz Centre for Infection Research (HZI) in Braunschweig and MHH.

13.10.2022

CiiM

Back to the first page
...
39
40
41
42
...
149

HZI in the media

... erhielt das Projekt „Citrapeutics“ vom Helmholtz-Zentrum für Infektionsforschung (HZI) in Braunschweig eine Förderung in Höhe ...

25.11.2025

Bionity.COM

led by Hannover Medical School (MHH) and the Helmholtz Center for Infection Research (HZI) has now discovered clear molecular signatures for

24.11.2025

Medical Xpress

Medizinischen Hochschule Hannover (MHH) und dem Helmholtz-Zentrum für Infektionsforschung (HZI), hat nun eindeutige molekulare Signaturen ...

24.11.2025

DeutschesGesundheitsPortal

Braunschweig. Das Helmholtz-Zentrum für Infektionsforschung (HZI) bringt anlässlich seines 60. Jubiläums seine Forschung vom 3. ...

22.11.2025

Regional Heute

Universität Hannover (LUH), dem Helmholtz Zentrum für Infektionsforschung (HZI) in Braunschweig, der Technischen Universität Braunschweig ...

21.11.2025

Medizinische Hochschule Hannover

... 38100 Braunschweig Das Helmholtz-Zentrum für Infektionsforschung: Wissenschaftler:innen am Helmholtz-Zentrum für Infektionsforschung ( ...

20.11.2025

Bochumer-Zeitung

Dr. Dunja Bruder ist Forschungsgruppenleiterin am Helmholtz-Zentrum für Infektionsforschung in Braunschweig und zugleich Professorin für

20.11.2025

Bilanz

... Wissenschaftler und Wissenschaftlerinnen des Helmholtz-Zentrums für Infektionsforschung (HZI) und der Medizinischen Hochschule ...

19.11.2025

Rheinische Post

... Forschungsschwerpunkt „Neue Antiinfektiva“ des Helmholtz-Zentrums für Infektionsforschung (HZI) entwickeln fast 20 Forschungsgruppen neue ...

18.11.2025

Regional Heute

... , Stellvertretende Teamleiterin der Klinischen Epidemiologie am Helmholtz-Zentrum für Infektionsforschung (HZI), Braunschweig.

17.11.2025

Biermann Medizin

... und individueller Darmflora ab.

Forscher am Helmholtz-Zentrum für Infektionsforschung arbeiten bereits an der nächsten Generation ...

14.11.2025

Ad Hoc News

Klett-Tammen, Abteilung Epidemiologie (EPID), Helmholtz-Zentrum für Infektionsforschung (

HZI

), Braunschweig. Grundsätzlich sei auch die ...

13.11.2025

Deutsches Ärzteblatt

Register now for the HZI-Newsletter

and stay up to date!

Email address *

We use rapidmail to send our newsletter. I agree that my data entered here will be transmitted to rapidmail. I have taken note of the HZI's privacy policy and have been informed of my rights.